A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a loss of -21.69%.However, over the last six months, we can see a stronger performance of -38.13%. Over the last 30 days, the price of RLAY has leaped by -2.90%. And in the last five days, it has surged by 17.12%.
Relay Therapeutics Inc. (RLAY) currently has a stock price of $11.70. The stock saw a sharp increase in the last trading session, hitting a high of $12.13 after opening at $11.15. The lowest recorded price for the day was $11.15 before it closed at $11.10.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Relay Therapeutics Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $33.06 on 09/08/22, and the lowest price during the same period was recorded at $9.67 on 05/16/23.
52-week price history of RLAY Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Relay Therapeutics Inc.’s current trading price is -64.61% away from its 52-week high, while its distance from the 52-week low is 20.99%. The stock’s price range over this timeframe has been between $9.67 and $33.06. The shares of the Healthcare sector company recorded a trading volume of approximately 2.74 million for the day, which was comparatively higher than the average daily volume of 1.58 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Relay Therapeutics Inc. (RLAY) has experienced a quarterly decline of -33.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.38B and boasts a workforce of 328 employees.
Expert Opinions: Analysts’ Ratings for Relay Therapeutics Inc.
As of right now, 9 analysts are rating Relay Therapeutics Inc. as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.06, with a change in price of -2.46. Similarly, Relay Therapeutics Inc. recorded 1,532,584 in trading volume during the last 100 days, posting a change of -17.37%.
RLAY’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for RLAY stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
RLAY Stock Stochastic Average
Relay Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 21.23%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 82.52%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 54.45% and 35.95%, respectively.